BioPharmSignal logoBioPharmSignal

Biotech News

Humana Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Financial Guidance

Humana (HUM)HumanaEarnings

Reports 4Q25 net loss per share of $6.61 on a GAAP basis, Adjusted net loss per share of $3.96; reports full year (FY) 2025 earnings per share (EPS) of $9.84 on a GAAP basis, $17.14 on an Adjusted basis; quarterly and FY Adjusted results in line with management's expectations 4Q25 Insurance segment

Related news

HUMHumana2026-07-29 10:00 EST

Humana Reports Second Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance

HUMHumana2026-04-29 10:00 EST

Humana Reports First Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance

View all latest news

Humana

Senior-Focused Health Insurance Humana is a health and wellness company centered on Medicare Advantage and other government-sponsored health plans. Its insurance operations coordinate benefits, provider networks and care programs for seniors and other eligible populations. Medicare Advantage Platform Individual Medicare Advantage is the...

Recent company news

HUMHumana2026-07-29 11:00 EST

Humana Elects Paul Smith and Frederick Crawford to Board of Directors

HUMHumana2026-07-29 10:00 EST

Humana Reports Second Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance

HUMHumana2026-06-22 20:30 EST

Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026

HUMHumana2026-06-10 20:30 EST

Humana Announces Agreement to Divest Minority Interest in Gentiva

HUMHumana2026-04-29 10:00 EST

Humana Reports First Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance

Stock data

Close
367.24 USD
Market cap
38.53B USD
Exchange
NYSE
Sector
Biopharma
Location
United States